Your session is about to expire
← Back to Search
Remote Intervention for High Blood Pressure (CP&R Trial)
N/A
Waitlist Available
Led By Deborah Reynolds, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The patient is > 18 years of age at enrollment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months prior to screening and week 12
Awards & highlights
CP&R Trial Summary
This trial looks at if blood pressure and cholesterol can predict who needs medical help and if a remote intervention can help.
Who is the study for?
This trial is for adults over 18 with high blood pressure and cholesterol, who've been on medication for these conditions in the past year. They must be able to communicate in English or Spanish and have variable blood pressure readings. It's not suitable for those with recent severe cardiovascular events, unstable vital signs, certain psychiatric conditions, or heart failure.Check my eligibility
What is being tested?
The study tests a remote intervention method to manage high blood pressure by reviewing patients' electronic health records (EHR) for blood pressure and cholesterol levels fluctuations. The goal is to see if at-risk patients can be identified and effectively engaged through this approach.See study design
What are the potential side effects?
Since this trial involves a non-drug intervention focusing on monitoring and communication rather than medication changes, there are no direct side effects from drugs being tested. However, participants may experience stress or anxiety related to regular health monitoring.
CP&R Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
CP&R Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months prior to screening and week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months prior to screening and week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Blood pressure readings
Secondary outcome measures
Change in Blood Pressure Variability Index
Change in blood pressure
Change in cholesterol level
+3 moreCP&R Trial Design
1Treatment groups
Experimental Treatment
Group I: Remote InterventionExperimental Treatment1 Intervention
An automatic blood pressure monitor will be given to patients upon enrollment. During the three months after enrollment, patients will be administered remote intervention weekly during the first month, and biweekly during the second and third month. At the onset of those sessions the patients will be asked to measure their blood pressure and this will be recorded by the coordinator.
Find a Location
Who is running the clinical trial?
Edward-Elmhurst Health SystemOTHER
4 Previous Clinical Trials
421 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,261 Total Patients Enrolled
Deborah Reynolds, MDPrincipal InvestigatorEdward-Elmhurst Health System
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your blood pressure has varied a lot in the past year.I have a condition that makes controlling my blood pressure very hard.I have had a heart rhythm problem treated in the last 6 months.I am older than 18 years.My heart's pumping ability is weak.My blood pressure and cholesterol levels have been stable for the last 3 months.I have been treated for high blood pressure and high cholesterol for over a year.I can understand and speak English or Spanish well enough to follow study instructions.I haven't had a heart attack, stroke, or similar event in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Remote Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this investigation currently require additional participants?
"Based on the clinicaltrials.gov report, this medical trial is actively recruiting patients and has been since April 10th 2023. The trial was last updated on April 17th of the same year."
Answered by AI
What is the upper limit of participants for this medical experiment?
"Affirmative, the information on clinicaltrials.gov attests to this research being presently recruiting participants. It was initiated on April 10th 2023 and updated lastly on April 17th of that same year. This trial necessitates a total of 20 individuals from one location."
Answered by AI
Share this study with friends
Copy Link
Messenger